Literature DB >> 22922667

The evaluation of neutrophil-lymphocyte ratio in Alzheimer's disease.

Mehmet Emin Kuyumcu1, Yusuf Yesil, Zeynel Abidin Oztürk, Cemal Kizilarslanoğlu, Sezgin Etgül, Meltem Halil, Zekeriya Ulger, Mustafa Cankurtaran, Servet Arıoğul.   

Abstract

BACKGROUND/AIM: There is growing consensus in the literature that inflammation plays a significant role in the pathophysiology of Alzheimer's disease (AD). The blood neutrophil-lymphocyte ratio (NLR) is a new, inexpensive and easily applicable marker of inflammation. The aim of this study was to investigate the association between NLR, as an inflammatory biomarker, and AD.
METHODS: 241 AD patients and 175 patients with normal cognitive function were evaluated in this study.
RESULTS: The mean ± SD NLR of AD patients was significantly higher than that of patients with normal cognitive function (3.21 ± 1.35 vs. 2.07 ± 0.74, p < 0.001, respectively). Receiver operating characteristic curve analysis suggested that the optimum NLR cutoff point for AD was 2.48 with 69.29% sensitivity, 79.43% specificity, 82.30% positive predictive values and 65.30% negative predictive values. Logistic regression analysis showed that elevated NLR (OR: 4.774, 95% CI: 2.821-8.076, p < 0.001) was an independent variable for predicting AD.
CONCLUSION: Elderly people with AD have higher NLR than healthy controls. Elevated NLR levels are usually considered as an inflammatory marker. The results of this study suggested that inflammation plays a role in the pathogenesis of AD.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22922667     DOI: 10.1159/000341583

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  51 in total

1.  Peripheral leukocyte populations and oxidative stress biomarkers in aged dogs showing impaired cognitive abilities.

Authors:  Paolo Mongillo; Daniela Bertotto; Elisa Pitteri; Annalisa Stefani; Lieta Marinelli; Gianfranco Gabai
Journal:  Age (Dordr)       Date:  2015-04-24

2.  Neutrophil-lymphocyte ratio as a new predictive and prognostic factor at the hearing loss of diabetic patients.

Authors:  Sahin Ulu; Abdulkadir Bucak; M Sena Ulu; Ahmet Ahsen; Abidin Duran; Fatih Yucedag; Abdullah Aycicek
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10       Impact factor: 2.503

3.  Early prediction of severity in acute ischemic stroke and transient ischemic attack using platelet parameters and neutrophil-to-lymphocyte ratio.

Authors:  Hyeon-Ho Lim; In-Hwa Jeong; Gyu-Dae An; Kwang-Sook Woo; Kyeong-Hee Kim; Jeong-Man Kim; Jae-Kwan Cha; Jin-Yeong Han
Journal:  J Clin Lab Anal       Date:  2018-11-09       Impact factor: 2.352

4.  Relationship between Neutrophil-to-Lymphocyte Ratio and Stress in Multiple Sclerosis Patients.

Authors:  Fawaz Al-Hussain; Meshal Mohammed Alfallaj; Abdulaziz Nasser Alahmari; Abdullah Nasser Almazyad; Talal Khalid Alsaeed; Abdulmjeed Abdulaziz Abdurrahman; Ghulam Murtaza; Shahid Bashir
Journal:  J Clin Diagn Res       Date:  2017-05-01

5.  Associations between perceived discrimination and immune cell composition in the Jackson Heart Study.

Authors:  Jacob E Aronoff; Edward B Quinn; Allana T Forde; Láshauntá M Glover; Alexander Reiner; Thomas W McDade; Mario Sims
Journal:  Brain Behav Immun       Date:  2022-04-02       Impact factor: 19.227

6.  Neutrophil-lymphocyte ratio as a predictor of cognitive dysfunction in carotid endarterectomy patients.

Authors:  Hadi J Halazun; Joanna L Mergeche; Kaitlin A Mallon; E Sander Connolly; Eric J Heyer
Journal:  J Vasc Surg       Date:  2014-03       Impact factor: 4.268

7.  Investigation of the prognostic role of neutrophil-to-lymphocyte ratio in Idiopathic Sudden Sensorineural Hearing Loss based on propensity score matching: a retrospective observational study.

Authors:  Shiyuan Wu; Zaizai Cao; Fangling Shi; Bobei Chen
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-03-13       Impact factor: 2.503

8.  The Association Between Neutrophil/Lymphocyte Ratio and Disease Activity in Rheumatoid Arthritis and Ankylosing Spondylitis.

Authors:  Ridvan Mercan; Berivan Bitik; Abdurrahman Tufan; Utku Burak Bozbulut; Nuh Atas; Mehmet Akif Ozturk; Seminur Haznedaroglu; Berna Goker
Journal:  J Clin Lab Anal       Date:  2015-12-14       Impact factor: 2.352

9.  The Relationship Between Serum Pentraxine 3 Levels and Hematological Markers in Patients With Rheumatoid Arthritis.

Authors:  Mustafa Serdar Sağ; Sinem Sağ; İbrahim Tekeoğlu; Ayhan Kamanli; Kemal Nas; Halil Harman
Journal:  Arch Rheumatol       Date:  2017-09-13       Impact factor: 1.472

10.  Neutrophil-lymphocyte ratio in patients with major depressive disorder undergoing no pharmacological therapy.

Authors:  Süleyman Demir; Abdullah Atli; Mahmut Bulut; Aslıhan Okan İbiloğlu; Mehmet Güneş; Mehmet Cemal Kaya; Özlem Demirpençe; Aytekin Sır
Journal:  Neuropsychiatr Dis Treat       Date:  2015-08-27       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.